Total Payments
$1,856
2024 Payments
$1,253
Companies
17
Transactions
87
Medicare Patients
417
Medicare Billing
$82,951

Payment Breakdown by Category

Food & Beverage$1,819 (98.0%)
Education$36.86 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,819 84 98.0%
Education $36.86 3 2.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $380.41 19 $0 (2024)
Otsuka America Pharmaceutical, Inc. $275.51 11 $0 (2024)
Aurinia Pharma U.S., Inc. $251.11 9 $0 (2024)
Amgen Inc. $224.59 10 $0 (2024)
Travere Therapeutics, Inc. $175.95 11 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $113.53 6 $0 (2024)
CorMedix Inc. $67.97 2 $0 (2024)
Ardelyx, Inc. $66.10 3 $0 (2024)
GlaxoSmithKline, LLC. $53.49 3 $0 (2024)
Kyowa Kirin, Inc. $52.57 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,253 55 AstraZeneca Pharmaceuticals LP ($332.81)
2023 $480.57 26 Otsuka America Pharmaceutical, Inc. ($105.02)
2022 $122.61 6 Bayer HealthCare Pharmaceuticals Inc. ($32.62)

All Payment Transactions

87 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/17/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.50 General
Category: GASTROENTEROLOGY
12/11/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $26.23 General
Category: Cardiovascular and Metabolism
12/10/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.90 General
Category: Cardiovascular and Metabolism
12/03/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $28.63 General
Category: NEPHROLOGY
11/20/2024 CorMedix Inc. DefenCath (Drug) Food and Beverage In-kind items and services $42.12 General
Category: Catheter Lock Solution
11/12/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $25.72 General
Category: NEPHROLOGY
11/05/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.85 General
Category: Cardiovascular and Metabolism
11/04/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $24.67 General
Category: GASTROENTEROLOGY
10/28/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $19.85 General
10/15/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $20.57 General
Category: NEPHROLOGY
10/14/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $22.19 General
Category: Immunology
10/10/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.37 General
Category: Cardiovascular and Metabolism
10/08/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.27 General
Category: Cardio-renal
10/02/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $21.12 General
10/01/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $28.24 General
Category: LUPUS NEPHRITIS
10/01/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $17.28 General
Category: Cardiovascular and Metabolism
09/23/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $26.29 General
Category: Nephrology
09/17/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.92 General
Category: Inflammation/Rare Disease
09/16/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $24.39 General
09/10/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $22.06 General
Category: NEPHROLOGY
09/09/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $15.32 General
Category: Cardiovascular and Metabolism
09/05/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $27.98 General
Category: LUPUS NEPHRITIS
08/28/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $19.93 General
Category: GASTROENTEROLOGY
08/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $28.31 General
Category: NEPHROLOGY
08/20/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.41 General
Category: Inflammation/Rare Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 374 838 $289,413 $76,637
2022 3 43 77 $24,151 $6,314
Total Patients
417
Total Services
915
Medicare Billing
$82,951
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 83 286 $59,202 $16,863 28.5%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 17 62 $65,162 $16,680 25.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 51 139 $41,283 $12,422 30.1%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 19 52 $45,261 $11,657 25.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 49 77 $20,482 $4,967 24.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 39 42 $24,150 $4,967 20.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 30 33 $12,540 $3,184 25.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 36 $13,536 $3,054 22.6%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 35 66 $7,392 $2,465 33.4%
36415 Insertion of needle into vein for collection of blood sample Office 2023 25 45 $405.00 $378.00 93.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 13 34 $10,098 $2,642 26.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 12 14 $8,050 $2,104 26.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 18 29 $6,003 $1,568 26.1%

About Dr. Bassem Arab, MD

Dr. Bassem Arab, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1780116061.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bassem Arab, MD has received a total of $1,856 in payments from pharmaceutical and medical device companies, with $1,253 received in 2024. These payments were reported across 87 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,819).

As a Medicare-enrolled provider, Arab has provided services to 417 Medicare beneficiaries, totaling 915 services with total Medicare billing of $82,951. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.

Practice Information

Products in Payments

  • FARXIGA (Drug) $286.27
  • JYNARQUE (Drug) $275.51
  • LUPKYNIS (Drug) $251.11
  • KRYSTEXXA (Biological) $218.40
  • Kerendia (Drug) $113.53
  • LOKELMA (Drug) $73.02
  • DefenCath (Drug) $67.97
  • IBSRELA (Drug) $66.10
  • RAYALDEE (Drug) $49.85
  • TARPEYO (Drug) $44.55
  • BENLYSTA (Biological) $40.00
  • Crysvita (Drug) $25.03
  • Fabhalta (Drug) $22.19
  • TAVNEOS (Drug) $21.44
  • CRYSVITA (Drug) $17.75
  • Parsabiv (Drug) $16.96
  • Korsuva (Drug) $14.71
  • JESDUVROQ (Drug) $13.49
  • MOUNJARO (Drug) $13.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in San Antonio